Poria

Metadata

Regulatory Status

Chinese Pharmacopoeia

• Listed: Yes. Fu Ling is one of the most established official drugs in the Chinese Pharmacopoeia (2020 edition).
• Traditional indications: Promoting urination and draining dampness, strengthening the spleen and harmonizing the middle burner, calming the mind and tranquilizing the spirit. Indicated for edema, phlegm-dampness, diarrhea due to spleen deficiency, palpitations, insomnia, and dizziness.
• Classification: Sweet and bland in taste, neutral in nature. Enters the Heart, Lung, Spleen, and Kidney meridians. Classified as a superior-grade herb in the Shennong Bencao Jing (circa 200 CE), indicating suitability for long-term use.
• Historical significance: Fu Ling is considered one of the most important herbs in the entire TCM materia medica. It is estimated to appear in 10-20% of all classical prescriptions, making it one of the most frequently prescribed traditional medicines in Chinese history.

Japanese Pharmacopoeia

• Listed: Yes. Bukuryo (Poria Sclerotium) is an official drug in the Japanese Pharmacopoeia.
• Kampo use: Poria is a component of numerous Kampo formulas including Goreisan (Wu Ling San), Hochu-ekki-to (Bu Zhong Yi Qi Tang), and Rikkunshi-to (Liu Jun Zi Tang). These Kampo formulas are covered by Japanese national health insurance.

Korean Pharmacopoeia

• Listed: Yes. Bukryeong is an official drug in the Korean Pharmacopoeia and a key ingredient in many traditional Korean medicine (Hanbang) formulations.

European Union

• No EMA/HMPC monograph. Poria is not established in European phytotherapy tradition.
• Novel Food: Not specifically authorized under Regulation (EU) 2015/2283.

United States

• Dietary supplement: Available as a dietary supplement under DSHEA, typically marketed for digestive and immune support.
• Traditional use recognition: Recognized in the US Pharmacopoeia as a traditional Chinese medicine ingredient.

Conditions & Indications

Primary Indications (Moderate Evidence)

• Gut health and digestive support (spleen-strengthening) — Poria is traditionally indicated for spleen deficiency patterns characterized by poor digestion, loose stools, bloating, and fatigue. Pachymaran polysaccharides demonstrate prebiotic effects, promoting beneficial gut microbiota growth. Li et al. (2019) showed that Poria polysaccharides modulated gut microbiota composition in animal models, increasing Lactobacillus and Bifidobacterium populations while reducing pathogenic bacteria. The traditional TCM classification as a spleen-strengthening agent aligns with modern understanding of its prebiotic and gut barrier-supporting properties.
• Diuretic and anti-edema effects — Poria is one of the primary diuretic agents in TCM, used for edema, urinary difficulty, and dampness accumulation. The classic formula Wu Ling San (Five Ingredient Powder with Poria) is one of the most prescribed diuretic formulas in East Asian medicine. The diuretic mechanism is attributed to triterpenoid compounds (pachymic acid, tumulosic acid) that modulate aquaporin expression and renal tubular water reabsorption without significant electrolyte depletion.

Secondary Indications (Preliminary Evidence)

• Immunomodulation — Pachymaran (beta-1,3-D-glucan) activates macrophages and enhances splenocyte proliferation through Dectin-1 and TLR-2 signaling. Zhang et al. (2013) demonstrated that Poria polysaccharides enhanced immune cell activity in cyclophosphamide-immunosuppressed mice.
• Calming and anxiolytic effects (an shen) — Traditional indication for palpitations, anxiety, and insomnia. Fu Shen (the portion of sclerotium surrounding the pine root) is specifically used for calming. Preclinical evidence supports GABA-ergic modulation and anxiolytic activity. Shah et al. (2014) demonstrated anxiolytic effects of Poria triterpenoids in animal models.
• Anti-inflammatory activity — Pachymic acid and dehydrotumulosic acid inhibit NF-kB signaling and suppress pro-inflammatory cytokine production. These triterpenoids also inhibit phospholipase A2 and cyclooxygenase activity.

Emerging/Preclinical Indications

• Anti-tumor activity — Pachymic acid and poricoic acids demonstrate anti-proliferative effects against various cancer cell lines through apoptosis induction, cell cycle arrest, and NF-kB inhibition. Ling et al. (2011) showed that Poria polysaccharides inhibited tumor growth in S180 sarcoma-bearing mice.
• Nephroprotective effects — Poria extracts demonstrate kidney-protective effects in animal models of renal injury, consistent with its traditional renal-supporting indications.
• Anti-hyperglycemic activity — Poria polysaccharides reduce blood glucose in diabetic animal models through enhanced insulin sensitivity and modulation of hepatic glucose metabolism.
• Gut barrier protection — Poria polysaccharides enhance intestinal tight junction protein expression and reduce intestinal permeability in animal models of gut barrier dysfunction, supporting the traditional spleen-strengthening indication.

Mechanism of Action

Primary Mechanisms

1. Pachymaran polysaccharide prebiotic and immunomodulatory activity Pachymaran is a beta-1,3-D-glucan polysaccharide with beta-1,6-linked branches that constitutes the primary water-soluble bioactive fraction of Poria. Pachymaran acts as a prebiotic, promoting the growth of beneficial gut bacteria (Lactobacillus, Bifidobacterium) while inhibiting pathogenic species. The prebiotic effect modulates short-chain fatty acid (SCFA) production, particularly butyrate, which nourishes colonocytes and maintains gut barrier integrity. Pachymaran also activates innate immune cells through Dectin-1 and TLR-2 signaling on macrophages and dendritic cells, enhancing phagocytic activity and cytokine production. This dual prebiotic-immunomodulatory mechanism connects gut health to systemic immune function.

2. Triterpenoid anti-inflammatory and diuretic activity Poria contains over 50 lanostane-type triterpenoids, with pachymic acid, tumulosic acid, dehydrotumulosic acid, and eburicoic acid as principal compounds. These triterpenoids exert multiple mechanisms:

• Anti-inflammatory: Inhibition of NF-kB signaling, suppression of COX-2 and iNOS expression, and reduction of pro-inflammatory cytokines (TNF-alpha, IL-1beta, IL-6). Pachymic acid also inhibits phospholipase A2 activity.
• Diuretic: Modulation of aquaporin-2 (AQP2) expression in renal collecting ducts, promoting water excretion without significant electrolyte loss. This mechanism distinguishes Poria’s diuretic effect from loop and thiazide diuretics that cause potassium depletion.
• Anxiolytic: GABA-A receptor modulation and enhancement of GABAergic neurotransmission, contributing to the traditional calming and spirit-quieting indication.

3. Gut barrier enhancement Poria polysaccharides enhance intestinal epithelial tight junction protein expression (occludin, claudin-1, ZO-1), reducing intestinal permeability. This gut barrier-protective effect, combined with prebiotic activity, provides a mechanistic basis for the traditional TCM concept of “strengthening the spleen” and its application in diarrhea and digestive weakness.

Key Active Compounds

Pharmacological Note

Poria shares a dual polysaccharide-triterpenoid pharmacology with reishi, though the compound classes differ: Poria contains pachymaran (beta-1,3-D-glucan) and lanostane-type triterpenoids (pachymic acid family), while reishi contains different beta-glucan structures and ganoderic acid triterpenoids. Like reishi, dual extraction (hot water + ethanol) captures both compound classes. Traditional TCM processing distinguishes different parts of the Poria sclerotium for different therapeutic purposes — a level of pharmacological differentiation within a single organism that is unique to Poria among medicinal fungi. The “spleen-strengthening” and “dampness-draining” TCM classifications are now understood to reflect gut microbiome modulation, gut barrier enhancement, and renal aquaporin-mediated diuresis, respectively.

Clinical Evidence Summary

Formula-Based Clinical Evidence

Most clinical evidence for Poria comes from studies of traditional multi-herb formulas in which it is a component:

Standalone Poria Studies

Evidence Limitations

• The most significant limitation is that Poria has been studied primarily as a component of multi-herb formulas rather than as a standalone agent. Isolating its individual contribution from formula-based clinical evidence is difficult.
• Standalone clinical trials in humans are very limited; most evidence is preclinical.
• The formula-based evidence, while extensive, reflects the synergistic approach of TCM rather than single-agent pharmacology.
• Standardization of Poria products varies; the polysaccharide-to-triterpenoid ratio depends on the part of the sclerotium used and the extraction method.
• Publication bias toward positive results in the Chinese-language literature is a concern.
• Despite over 2,000 years of traditional use and pharmacopoeia listing in three countries, modern evidence-based medicine standards have not been fully met for most indications.

Safety Profile

General Assessment

Poria has been consumed as food and medicine for over 2,000 years in East Asia and is classified as a superior-grade herb in classical TCM texts, indicating suitability for long-term use without toxicity. Its classification as bland and neutral in TCM suggests low potential for adverse effects. No serious adverse events have been reported in the published literature.

Contraindications

• Excessive urination or dehydration: Due to diuretic effects, Poria should be used with caution in patients with existing dehydration, excessive urination, or electrolyte imbalance.
• Yin deficiency with heat signs (TCM): Traditional contraindication for patients presenting with yin deficiency patterns characterized by dryness and heat, as Poria’s dampness-draining action could theoretically exacerbate fluid depletion.
• Pregnancy and lactation: Traditional use during pregnancy is documented in some classical formulas under practitioner supervision, but modern safety data for concentrated extracts is lacking.

Drug Interactions

• Diuretic medications (furosemide, hydrochlorothiazide, spironolactone): Potential additive diuretic effect. Though Poria’s diuretic mechanism (aquaporin modulation) differs from pharmaceutical diuretics, combined use could increase fluid and electrolyte loss. Severity: Low-to-moderate. Monitor fluid balance.
• Immunosuppressants: Pachymaran’s immunomodulatory activity could theoretically counteract immunosuppressive therapy. Severity: Moderate. Consult specialist.
• Sedatives and anxiolytics (benzodiazepines, barbiturates): Potential additive CNS depressant effects due to GABAergic activity of Poria triterpenoids. Severity: Low. Monitor for excessive sedation.
• Antidiabetic agents: Preclinical evidence of hypoglycemic activity; additive blood glucose lowering is theoretically possible. Severity: Low. Monitor blood glucose.

Side Effects

• Common: Generally very well-tolerated. Mild gastrointestinal effects (loose stools, increased urination) at higher doses.
• Uncommon: Allergic reactions are rare.
• Rare: No serious adverse events reported in the published literature.

Pregnancy and Lactation

• Category: Traditional use during pregnancy is documented in classical TCM formulas (e.g., certain pregnancy-safe formulas include Poria), but concentrated extracts lack modern reproductive safety data. Consult a qualified practitioner.

Clinical Dosage

Dried Sclerotium

• Standard dose: 9-15 g/day (per Chinese Pharmacopoeia, 2020 edition)
• Preparation: Traditionally sliced and decocted in water for 30-60 minutes
• Forms: Bai Fu Ling (white inner portion, general use), Chi Fu Ling (reddish portion, urinary support), Fu Ling Pi (outer skin, edema), Fu Shen (root-surrounding portion, calming)

Polysaccharide Extract

• Standard dose: 1-3 g/day of hot water extract standardized to polysaccharide/pachymaran content
• This preparation primarily captures the prebiotic and immunomodulatory fraction

Dual-Extract Tincture

• Standard dose: 2-4 mL of 1:5 dual-extract tincture (hot water + ethanol), two to three times daily
• Captures both water-soluble polysaccharides and alcohol-soluble triterpenoids

As Component of TCM Formulas

• Standard dose: 9-15 g within classical formulas such as Si Jun Zi Tang, Wu Ling San, or Gui Zhi Fu Ling Wan
• Note: Dosing within formulas follows established traditional proportions and should be guided by a qualified TCM practitioner

Powdered Sclerotium

• Standard dose: 3-6 g/day of powdered sclerotium in capsules
• Note: The sclerotium is dense and starchy; powdering improves bioactive extraction in the GI tract compared to whole slices

Sources

• Chinese Pharmacopoeia Commission. Pharmacopoeia of the People’s Republic of China. Vol 1. 2020 Edition
• Li X, He Y, Zeng P, et al. Molecular basis for Poria cocos mushroom polysaccharide used as an antitumour drug in China. J Cell Mol Med. 2019;23(1):4-20
• Zhang M, Chiu LC, Cheung PC, Ooi VE. Growth-inhibitory effects of a beta-glucan from the mycelium of Poria cocos on human breast carcinoma MCF-7 cells: cell-cycle arrest and apoptosis induction. Oncol Rep. 2006;15(3):637-643
• Ling H, Zhang Y, Ng KY, Chew EH. Pachymic acid impairs breast cancer cell invasion by suppressing nuclear factor-kB-dependent matrix metalloproteinase-9 expression. Breast Cancer Res Treat. 2011;126(3):609-620
• Wang Y, Zhang L, Li Y, et al. Chemical analysis of Poria cocos polysaccharides and their anti-tumor properties. Int J Biol Macromol. 2004;34(3):183-187
• Zhao YY, Feng YL, Du X, et al. Diuretic activity of the ethanol and aqueous extracts of the surface layer of Poria cocos in rat. J Ethnopharmacol. 2012;144(3):775-778
• Shah VK, Choi JJ, Han JY, Lee MK, Hong JT, Oh KW. Pachymic acid enhances pentobarbital-induced sleeping behaviors via GABAA-ergic systems in mice. Biomol Ther (Seoul). 2014;22(4):314-320
• Cuellar MJ, Giner RM, Recio MC, Just MJ, Manez S, Rios JL. Effect of the basidiomycete Poria cocos on experimental dermatitis and other inflammatory conditions. Chem Pharm Bull. 1997;45(3):492-494
• Sun Y. Structure and biological activities of the polysaccharides from the leaves, roots and fruits of Panax ginseng C.A. Meyer: An overview. Carbohydrate Polymers. 2011;85(3):490-499
• Tai T, Akahori A, Shingu T. A lanostane triterpenoid with anti-emetic activity from Poria cocos. Phytochemistry. 1995;39(5):1165-1169
• Fuchs SM, Heinemann C, Schliemann-Willers S, Hartmann H, Fluhr JW, Elsner P. Assessment of anti-inflammatory activity of Poria cocos in sodium lauryl sulphate-induced irritant contact dermatitis. Skin Res Technol. 2006;12(4):223-227
• Rios JL. Chemical constituents and pharmacological properties of Poria cocos. Planta Med. 2011;77(7):681-691
• Wang N, Liu D, Guo J, Sun Y, Guo T, Zhu X. Molecular mechanism of Poria cocos combined with oxaliplatin on the inhibition of epithelial-mesenchymal transition in gastric cancer cells. Biomed Pharmacother. 2018;102:865-873

Connections

• Poria shares a dual polysaccharide-triterpenoid pharmacology with Reishi (Ganoderma lucidum), though the specific compound classes differ. Poria’s pachymaran and pachymic acid parallel reishi’s beta-glucans and ganoderic acids, and both are extracted using dual (water + ethanol) methods.
• The traditional TCM pairing of Poria with Reishi in formulas like An Shen Ding Zhi Wan reflects complementary mechanisms: Poria drains dampness and calms the spirit through GABAergic modulation, while reishi nourishes qi and calms through adenosine-mediated pathways.
• Poria’s gut health applications complement Maitake (Grifola frondosa) and Turkey Tail (Trametes versicolor), which also contain prebiotic polysaccharides, though Poria’s traditional emphasis on spleen-strengthening and dampness-draining reflects more specific gut barrier and fluid balance mechanisms.
• Compare Poria’s diuretic triterpenoids (pachymic acid family) with Chaga (Inonotus obliquus) betulinic acid triterpenoids — both are lanostane-type compounds from the same biosynthetic pathway but with different pharmacological endpoints (diuretic vs. antioxidant/anti-tumor).
• Poria fills the gut-health category in this knowledge base, reflecting its traditional positioning as a digestive and fluid-regulating agent rather than a primarily immunomodulatory mushroom, distinguishing it from the immune-modulation focus of Turkey Tail, Reishi, Maitake, and Shiitake.
• Poria’s classification as a superior-grade herb suitable for long-term use parallels Reishi and Cordyceps in the Shennong Bencao Jing, reflecting the traditional assessment of exceptional safety among these medicinal fungi.